to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A Kauffman Foundation town hall meeting explored how the government, nonprofits and academic institutions could help enhance drug development and bring more effective drugs to market.
The Silicon Valley might not be the "friendliest" place to start your life science or digital health company. A small business survey released this month by the Kauffman Foundation and Thumbtack.com gave Austin, Virginia Beach, and Houston top honors as the friendliest cities for small businesses.
eMed has published the first in a series of white papers focused on issues key to life science and digital health entrepreneurs. The first white paper, Funding Sources for Life Science Startups, offers countless ideas on how to raise capital for a healthcare product: from a drug or device to the emerging health IT and mobile health segments.
Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.
Dinu Sen, CEO of Amplyx Pharmaceuticals, offers tips on finding need in the sector, hiring, and determining whether working with an accelerator is right for your company.
Anatomage, which launched in 2004 in San Jose, is an anatomy image software company specializing in 3D medical technology. In the almost-decade since starting the venture, CEO Jack Choi said he’s learned much about managing tight finances and knowing when to jump in – and when to throw in the towel.
Lisa Earnhardt, president and CEO of Intersect ENT, shares tips on finding your customer, working with physicians, and collaborating with the FDA.
STC Biologics is a Cambridge-based biotechnology company focused on the development of biologic drugs. Magdalena Leszczyniecka, the company’s president and CEO, launched the business just as the market crashed. After several years in the field, Leszczyniecka shared her experiences with bartering, negotiating, and asking for help.
"Med tech is alive and well, despite what we hear out there," Kevin Wasserstein, founder and principal at MentorCatalyst, told the attendees of today’s MedTech Investing Conference.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.